MedTrace Logo

Clinical Trials

NCT05636020 | ACTIVE_NOT_RECRUITING | NA
85 participants

Intervention to Change Affect Recognition and Empathy

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2023-03-15
Completion:
2027-02-28
Conditions
  • Traumatic Brain Injury
  • Concussion, Intermediate
  • Concussion, Severe
  • Concussion With LOC 31 to 59 Minutes
  • Concussion With Brief Loss of Consciousness
  • Traumatic Brain Injury With Brief Loss of Consciousness
  • Traumatic Brain Injury With Loss of Consciousness
  • Traumatic Brain Injury With Prolonged Loss of Consciousness
  • Traumatic Brain Injury (TBI); Concussion, Initial Encounter
  • Traumatic Brain Injury (TBI); Concussion, Subsequent Encounter
  • Traumatic Brain Injury With No Loss of Consciousness
  • Traumatic Brain Injury With Open Intracranial Wound
  • Traumatic Brain Injury With Moderate Loss of Consciousness
Interventions
  • BEHAVIORAL
No Results Yet
NCT05581004 | ACTIVE_NOT_RECRUITING | PHASE1
165 participants

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2022-10-20
Completion:
2028-07-31
Conditions
  • Locally Advanced or Metastatic Solid Tumors
  • NSCLC
  • HNSCC
  • Melanoma
  • TNBC
  • Esophageal Cancer
  • Gastric Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Urothelial Carcinoma
  • Clear Cell RCC
  • HCC
Interventions
  • DRUG
No Results Yet
NCT05483868 | ACTIVE_NOT_RECRUITING | PHASE1
55 participants

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2022-09-26
Completion:
2027-03-31
Conditions
  • Non-muscle-invasive Bladder Cancer
  • NMIBC
  • Non-Muscle Invasive Bladder Carcinoma
  • Non-Muscle Invasive Bladder Neoplasms
  • Non-Muscle Invasive Bladder Urothelial Carcinoma
  • Urothelial Carcinoma Bladder
Interventions
  • DRUG
  • COMBINATION_PRODUCT
No Results Yet
NCT05398185 | ACTIVE_NOT_RECRUITING | NA
241 participants

WiseApp for Spanish Speakers Living With HIV

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2023-03-01
Completion:
2026-11-01
Conditions
  • HIV Infections
  • Acquired Immune Deficiency Syndrome
  • Sexually Transmitted Diseases, Viral
Interventions
  • DEVICE
No Results Yet
NCT05372614 | RECRUITING | PHASE1
58 participants

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2022-10-05
Completion:
2028-07-17
Conditions
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Pancreatic Adenocarcinoma
  • Stage III Pancreatic Cancer AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8
  • Unresectable Malignant Solid Neoplasm
  • Unresectable Pancreatic Adenocarcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT05226507 | TERMINATED | PHASE1
45 participants

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2021-12-31
Completion:
2025-01-01
Conditions
  • Advanced Solid Tumor
  • Ovarian Cancer
  • Ovarian Clear Cell Carcinoma
  • Ovarian Clear Cell Tumor
  • Ovarian Clear Cell Adenocarcinoma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Endometrioid Tumor
  • ARID1A Gene Mutation
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page